Delivery Order SPE2DB22D2007-SPE2DB25FJ4RK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PADCEV 20 mg vials valued at $7,391.80 on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a $11,087.60 delivery order to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of August 8, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order was awarded on July 18, 2025, as part of AmerisourceBergen's broader engagement with the federal government for pharmaceutical supply. This delivery order falls under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.80 to AmerisourceBergen Drug Corp for the supply of PADCEV 30 mg vials. This contract is a firm fixed-price delivery order with no set-aside designation, issued competitively on July 21, 2025, and scheduled for completion by August 11, 2025. The products will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child...
- The Defense Logistics Agency awarded a $14,783.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 20 mg vials of Padcev, a specialized oncology medication. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), is scheduled for completion by October 6, 2025. The pharmaceutical will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, and no...
- The Defense Logistics Agency awarded a $22,175.20 delivery order to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of October 20, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for PADCEV 20 mg vials, with a ceiling value of $5,543.85 and a firm fixed price arrangement. The order is scheduled for completion by August 27, 2025. This is a non-set-aside, competitively awarded contract supporting the federal government's pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials. This competitively awarded, firm fixed price contract was executed on September 2, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical distributor will perform the delivery at its corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's continued...
- The Defense Logistics Agency awarded a $11,087.70 delivery order to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with performance to be completed by September 23, 2025. This competitively awarded, firm fixed-price contract is being executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of PADCEV 30 mg vials, a specialized pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $27.7K and is scheduled for completion by August 4, 2025. The contract was awarded competitively with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4RKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $8,315.70 to supply PADCEV 30 mg vials, a pharmaceutical product for oncology treatment. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. As the prime contractor for this comprehensive IDC, AmerisourceBergen supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company serves as a critical vendor for federal medical procurement, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive pharmaceutical distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/5/25 |